Human protein tyrosine phosphatase inhibitors and methods of use

Details for Australian Patent Application No. 2007265455 (hide)

Owner Warner Chilcott, LLC

Inventors Clark, Cynthia Monesa; Nichols, Ryan; Amarasinghe, Kande; Gray, Jeffrey Lyle; Maier, Mathew Brian

Agent Griffith Hack

Pub. Number AU-B-2007265455

PCT Pub. Number WO2008/002571

Priority 60/816,825 27.06.06 US

Filing date 27 June 2007

Wipo publication date 3 January 2008

Acceptance publication date 10 November 2011

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/425 (2006.01) - Thiazoles

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 February 2009 PCT application entered the National Phase

  PCT publication WO2008/002571 Priority application(s): WO2008/002571

21 May 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 26 Mar 2009

9 December 2010 Assignment before Grant

  THE PROCTER & GAMBLE COMPANY The application has been assigned to Warner Chilcott, LLC

10 November 2011 Application Accepted

  Published as AU-B-2007265455

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007265457-Bile acid derivatives as FXR ligands for the prevention or treatment of FXRmediated diseases or conditions

2007265454-Human protein tyrosine phosphatase inhibitors and methods of use